Literature DB >> 10354308

Inflammatory cytokines induce apoptotic and necrotic cell shedding from human proximal tubular epithelial cell monolayers

.   

Abstract

Acute tubular injury in sepsis is associated with proximal tubular epithelial cell (PTEC) detachment into the lumen leading to back-leakage of glomerular ultrafiltrate and tubule obstruction. Inflammatory cytokines, such as IL-1alpha, IFNgamma and TNFalpha, are important mediators in sepsis-induced acute renal failure, although their precise role is unclear. We used primary cultures of human PTEC to investigate the hypothesis that inflammatory cytokines exert cytotoxic effects and cause detachment of cells from adherent monolayers, possibly through the intermediate nitric oxide (NO). At 5 days post-confluence, PTEC monolayers were stimulated for 24 hours with IL-1alpha (10 ng/ml), IFNgamma (200 u/ml) and TNFalpha (10 ng/ml). Monolayer viability was assessed by a live/dead dual fluorescence labeling technique. Apoptosis within monolayers was determined by morphological examination and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL). PTEC in supernatants were counted and then analyzed by flow cytometry, using propidium iodide to assess cell viability and annexin V labeling to determine apoptosis. Results (mean +/- SEM; monolayers, n = 4; cell counts, n = 3; flow cytometry, n = 2) are shown below (at test, p < 0.05). Monolayers Supernatants Viable necrotic% of cells apoptotic countsx104/ml viable necrotic% of cells apoptotic Unstimulated 99.0+/-0.5 1.0+/-0.5 0 8.0+/-0.6a 64.6+/-2.5a 26.7+/-1.9a 6.2+/-0.6a Stimulated 92.4+/-3.2 7.6+/-3.2 0 14.7+/-0.6a 37.9+/-0.05a 48.0+/-0.3a 14.1+/-0.35a Following cytokine stimulation, there were significantly increased numbers of shed cells in supernatants. This cell population demonstrated significant loss of viability with increased numbers of both necrotic and apoptotic cells, as compared to unstimulated PTEC supernatants. Cytokine-stimulated monolayers maintained viability with no significant cell necrosis and no evidence of apoptosis. Preliminary experiments with the NO synthase inhibitor L-NMMA show that it reduces the number of cytokine-induced shed cells to the levels found in unstimulated cells (8.0 +/- 1.0 x 104/ml), although the percentages of necrotic and apoptotic cells are unchanged from cytokine-stimulated PTEC (44% and 15%, respectively). In conclusion, inflammatory cytokines induce necrotic and apoptotic cell shedding from PTEC monolayers with maintenance of monolayer viability. Preliminary data suggest that NO plays a cytotoxic role in this process.

Entities:  

Year:  1999        PMID: 10354308     DOI: 10.1046/j.1523-1755.2002.t01-1-00456.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  Human Tissue-Resident Mucosal-Associated Invariant T (MAIT) Cells in Renal Fibrosis and CKD.

Authors:  Becker M P Law; Ray Wilkinson; Xiangju Wang; Katrina Kildey; Kurt Giuliani; Kenneth W Beagley; Jacobus Ungerer; Helen Healy; Andrew J Kassianos
Journal:  J Am Soc Nephrol       Date:  2019-06-11       Impact factor: 10.121

2.  Nitric oxide inhibits the shedding of the glycosylphosphatidylinositol-anchored dipeptidase from porcine renal proximal tubules.

Authors:  Sung Wook Park; Hyun Joong Yoon; Hwanghee Blaise Lee; Nigel M Hooper; Haeng Soon Park
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

3.  Oxidants as important determinants of renal apoptosis during pneumoperitoneum: a study in an isolated perfused rat kidney model.

Authors:  Wisam Khoury; Avi A Weinbroum
Journal:  Surg Endosc       Date:  2011-12-17       Impact factor: 4.584

4.  Mechanisms of cardiac and renal dysfunction in patients dying of sepsis.

Authors:  Osamu Takasu; Joseph P Gaut; Eizo Watanabe; Kathleen To; R Eliot Fagley; Brian Sato; Steve Jarman; Igor R Efimov; Deborah L Janks; Anil Srivastava; Sam B Bhayani; Anne Drewry; Paul E Swanson; Richard S Hotchkiss
Journal:  Am J Respir Crit Care Med       Date:  2013-01-24       Impact factor: 21.405

5.  Unique molecular profile of exosomes derived from primary human proximal tubular epithelial cells under diseased conditions.

Authors:  Xiangju Wang; Ray Wilkinson; Katrina Kildey; Jeremy Potriquet; Jason Mulvenna; Richard J Lobb; Andreas Möller; Nicole Cloonan; Pamela Mukhopadhyay; Andrew J Kassianos; Helen Healy
Journal:  J Extracell Vesicles       Date:  2017-04-21

6.  Protective effect of resin adsorption on septic plasma-induced tubular injury.

Authors:  Vincenzo Cantaluppi; Viktoria Weber; Carola Lauritano; Federico Figliolini; Silvia Beltramo; Luigi Biancone; Massimo De Cal; Dinna Cruz; Claudio Ronco; Giuseppe Paolo Segoloni; Ciro Tetta; Giovanni Camussi
Journal:  Crit Care       Date:  2010-01-11       Impact factor: 9.097

7.  Circulating plasma factors induce tubular and glomerular alterations in septic burns patients.

Authors:  Filippo Mariano; Vincenzo Cantaluppi; Maurizio Stella; Giuseppe Mauriello Romanazzi; Barbara Assenzio; Monica Cairo; Luigi Biancone; Giorgio Triolo; V Marco Ranieri; Giovanni Camussi
Journal:  Crit Care       Date:  2008-03-25       Impact factor: 9.097

8.  The Mechanisms of Human Renal Epithelial Cell Modulation of Autologous Dendritic Cell Phenotype and Function.

Authors:  Sandeep Sampangi; Andrew J Kassianos; Xiangju Wang; Kenneth W Beagley; Travis Klein; Sadia Afrin; Helen Healy; Ray Wilkinson
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

Review 9.  Is boosting the immune system in sepsis appropriate?

Authors:  Jean-Marc Cavaillon; Damon Eisen; Djilalli Annane
Journal:  Crit Care       Date:  2014-03-24       Impact factor: 9.097

10.  Underlying Histopathology Determines Response to Oxidative Stress in Cultured Human Primary Proximal Tubular Epithelial Cells.

Authors:  Muhammad Ali Khan; Xiangju Wang; Kurt T K Giuliani; Purba Nag; Anca Grivei; Jacobus Ungerer; Wendy Hoy; Helen Healy; Glenda Gobe; Andrew J Kassianos
Journal:  Int J Mol Sci       Date:  2020-01-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.